Condensed Consolidating Financial Information - Condensed Consolidating Cash Flow Statement (Details) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | $5.80 | $7.80 |
Capital expenditures | -13.1 | -15.7 |
Acquisitions | 9.9 | 0 |
Net proceeds from dispositions | 0.7 | 0.5 |
Net cash flow provided by (used for) investing activities | -22.3 | -15.2 |
Proceeds from long-term debt borrowings - term loan and senior notes | 0 | 1,598 |
Proceeds from long-term debt borrowings - new senior notes | 103.8 | 0 |
Proceeds from borrowings under revolving credit facility | 105 | 0 |
Repayments of borrowings under revolving credit facility | -105 | 0 |
Deferred financing costs | -2.2 | -24.3 |
Proceeds from stock option exercises | 2 | 0 |
Taxes withheld for stock-based compensation | -3 | 0 |
Distribution of net debt proceeds to CBS | 0 | -1,523.80 |
Net cash contribution from CBS | 0 | 42.2 |
Dividends | -54.9 | 0 |
Intercompany | 0 | 0 |
Other | -0.4 | -0.1 |
Net cash flow provided by (used for) financing activities | 45.3 | 92 |
Effect of exchange rate changes on cash and cash equivalents | -1.3 | -0.5 |
Net increase in cash and cash equivalents | 27.5 | 84.1 |
Cash and cash equivalents at beginning of period | 28.5 | 29.8 |
Cash and cash equivalents at end of period | 56 | 113.9 |
Parent Company | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | -0.5 | 0 |
Capital expenditures | 0 | 0 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0 |
Net cash flow provided by (used for) investing activities | 0 | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 2 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of net debt proceeds to CBS | | 0 |
Net cash contribution from CBS | | 2.4 |
Dividends | -54.9 | |
Intercompany | 53.4 | -2.4 |
Other | 0 | 0 |
Net cash flow provided by (used for) financing activities | 0.5 | 0 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Subsidiary Issuer | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | -17.1 | 0 |
Capital expenditures | 0 | 0 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0 |
Net cash flow provided by (used for) investing activities | 0 | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 1,598 |
Proceeds from long-term debt borrowings - new senior notes | 103.8 | |
Proceeds from borrowings under revolving credit facility | 105 | |
Repayments of borrowings under revolving credit facility | -105 | |
Deferred financing costs | -2.2 | -24.3 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of net debt proceeds to CBS | | -1,523.80 |
Net cash contribution from CBS | | 0 |
Dividends | 0 | |
Intercompany | -75.6 | 20.5 |
Other | 0 | 0 |
Net cash flow provided by (used for) financing activities | 26 | 70.4 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 8.9 | 70.4 |
Cash and cash equivalents at beginning of period | 11.5 | 0 |
Cash and cash equivalents at end of period | 20.4 | 70.4 |
Guarantor Subsidiaries | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | 9.1 | 5.8 |
Capital expenditures | -12.1 | -12.2 |
Acquisitions | 9.9 | |
Net proceeds from dispositions | 0.7 | 0.3 |
Net cash flow provided by (used for) investing activities | -21.3 | -11.9 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | -3 | |
Distribution of net debt proceeds to CBS | | 0 |
Net cash contribution from CBS | | 39.8 |
Dividends | 0 | |
Intercompany | 21.9 | -11.7 |
Other | -0.4 | -0.1 |
Net cash flow provided by (used for) financing activities | 18.5 | 28 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 6.3 | 21.9 |
Cash and cash equivalents at beginning of period | 8.8 | 2.1 |
Cash and cash equivalents at end of period | 15.1 | 24 |
Non-Guarantor Subsidiaries | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | 14.3 | 2 |
Capital expenditures | -1 | -3.5 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0.2 |
Net cash flow provided by (used for) investing activities | -1 | -3.3 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of net debt proceeds to CBS | | 0 |
Net cash contribution from CBS | | 0 |
Dividends | 0 | |
Intercompany | 0.3 | -6.4 |
Other | 0 | 0 |
Net cash flow provided by (used for) financing activities | 0.3 | -6.4 |
Effect of exchange rate changes on cash and cash equivalents | -1.3 | -0.5 |
Net increase in cash and cash equivalents | 12.3 | -8.2 |
Cash and cash equivalents at beginning of period | 8.2 | 27.7 |
Cash and cash equivalents at end of period | 20.5 | 19.5 |
Eliminations | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | 0 | 0 |
Capital expenditures | 0 | 0 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0 |
Net cash flow provided by (used for) investing activities | 0 | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of net debt proceeds to CBS | | 0 |
Net cash contribution from CBS | | 0 |
Dividends | 0 | |
Intercompany | 0 | 0 |
Other | 0 | 0 |
Net cash flow provided by (used for) financing activities | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | $0 | $0 |